| |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation N21pN1 Donating Investigator Eva Eicher, The Jackson Laboratory
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000924 C57BL/6JEiJ | ||
| Considerations for Choosing Controls | ||
Strains carrying Wnt4tm1Amc allele
002866 129-Wnt4tm1Amc/J View Strains carrying Wnt4tm1Amc (1 strain)
Congenic Nomenclature
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Wnt4tm1Amc/Wnt4tm1Amc
involves: 129S1/Sv
- lethality-prenatal/perinatal
- perinatal lethality (MGI Ref ID J:21884)
- mutants die within 24 hrs of birth
- mutants are recovered at the expected mendelian frequency at late stages of gestation
- death is attributed to lack of kidney function
- renal/urinary system phenotype
- abnormal kidney development (MGI Ref ID J:21884)
- at E15 agenic kidneys consist of undifferentiated mesenchyme interspersed with branches of collecting duct epithelium
- reproductive system phenotype
- abnormal oogenesis (MGI Ref ID J:52554)
- reduced oocyte development
- at birth, ovaries have few oocytes and all are degenerating
- abnormal secondary sex determination (MGI Ref ID J:52554)
- Wolffian duct development and Mullerian duct regression are normal in males but both also occur in mutant females
- secondary sex reversal (MGI Ref ID J:52554)
- some Wolffian duct development is seen in mutant females proximal sex ducts of chromosomally XX mice appear masculinized at E18.5 and two Wolffian specific duct cell markers, Pax2 and Shh, identify a single ovary-associated duct with a highly convoluted proximal region resembling the epididymal region as a Wolffian duct derivative
- ectopic expression of Sertoli and Leidig cell marker occurs
- 3Beta-HSD and 17 alpha-hydroxylase are abnormally expressed in the ovary from E14.5 until birth
- MIS and Dhh are abnormally expressed in the ovary at birth
- Mullerian duct development is absent in females at E14.5 and specific Mullerian cell markers, Wnt-7a and Pax-8 are not detected
- hematopoietic system phenotype
- decreased thymocyte number (MGI Ref ID J:75999)
- at E15-E16, homozygotes show a 20-30% reduction in thymocyte number relative to wild-type embryos
- however, T cell maturation during fetal development appears unaffected
- immune system phenotype
- decreased thymocyte number (MGI Ref ID J:75999)
- at E15-E16, homozygotes show a 20-30% reduction in thymocyte number relative to wild-type embryos
- however, T cell maturation during fetal development appears unaffected
Wnt4tm1Amc/Wnt4tm1Amc
involves: 129/Sv * CD-1
- endocrine/exocrine gland phenotype
- abnormal adenohypophysis morphology (MGI Ref ID J:48144)
- the anterior pituitary is nearly devoid of all cell types except ACTH-expressing corticotropes
- decreased gonadotroph cell number (MGI Ref ID J:48144)
- decreased somatotroph cell number (MGI Ref ID J:48144)
- decreased thyrotroph cell number (MGI Ref ID J:48144)
- abnormal adrenal gland physiology (MGI Ref ID J:80420)
- adrenal glands appear morphologically normal but there is reduced aldosterone production in adrenal cortex
- ectopic expression of adrenal gland- pecific Cyp21 in gonads suggests abnormal migration of adrenal cells in early development
- nervous system phenotype
- abnormal adenohypophysis morphology (MGI Ref ID J:48144)
- the anterior pituitary is nearly devoid of all cell types except ACTH-expressing corticotropes
Wnt4tm1Amc/Wnt4tm1Amc
involves: 129/Sv * C57BL/6
- renal/urinary system phenotype
- abnormal kidney morphology (MGI Ref ID J:98831)
- severely hypoplastic metanephroi, that can form a few glomeruli, nephron tubules and medulla-like structures
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Wnt4tm1Amc related
Developmental Biology Research
Internal/Organ Defects (kidney)
Internal/Organ Research
Kidney Defects
| Allele Symbol | Wnt4tm1Amc | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Andrew P McMahon | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Wnt-4-; Wnt4n; | ||
| Mutation Made By | Andrew McMahon, Harvard University | ||
| Strain of Origin | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| ES Cell Line Name | CJ7 | ||
| ES Cell Line Strain | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| Gene Symbol and Name | Wnt4, wingless-related MMTV integration site 4 | ||
| Chromosome | 4 | ||
| Gene Common Name(s) | MGC112773; SERKAL; WNT-4; Wnt-4; | ||
| Molecular Note | Exon 3, encoding amino acids 106 through 196, was replaced by a PGK-neo cassette. The occasional expression of the targeted locus was observed in poorly developed aggregates in the kidneys of homozygous mutant mice via in situ hybridization. Expression was unaltered in the central nervous system and mesonephric mesenchyme. [MGI Ref ID J:21884] | ||
Genotyping Protocols
Wnt4tm1Amc, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Stark K; Vainio S; Vassileva G; McMahon AP. 1994. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372(6507):679-83. [PubMed: 7990960] [MGI Ref ID J:21884]
Wnt4tm1Amc relatedChassot AA; Ranc F; Gregoire EP; Roepers-Gajadien HL; Taketo MM; Camerino G; de Rooij DG; Schedl A; Chaboissier MC. 2008. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum Mol Genet 17(9):1264-77. [PubMed: 18250098] [MGI Ref ID J:133933]
Coveney D; Ross AJ; Slone JD; Capel B. 2007. A microarray analysis of the XX Wnt4 mutant gonad targeted at the identification of genes involved in testis vascular differentiation.(Correction: 2008; 8:529-537) Gene Expr Patterns 7(1-2):82-92. [PubMed: 16844427] [MGI Ref ID J:116022]
Heikkila M; Peltoketo H; Leppaluoto J; Ilves M; Vuolteenaho O; Vainio S. 2002. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143(11):4358-65. [PubMed: 12399432] [MGI Ref ID J:80420]
Heikkila M; Prunskaite R; Naillat F; Itaranta P; Vuoristo J; Leppaluoto J; Peltoketo H; Vainio S. 2005. The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology 146(9):4016-23. [PubMed: 15932923] [MGI Ref ID J:129451]
Itaranta P; Chi L; Seppanen T; Niku M; Tuukkanen J; Peltoketo H; Vainio S. 2006. Wnt-4 signaling is involved in the control of smooth muscle cell fate via Bmp-4 in the medullary stroma of the developing kidney. Dev Biol 293(2):473-83. [PubMed: 16546160] [MGI Ref ID J:108713]
Jeays-Ward K; Dandonneau M; Swain A. 2004. Wnt4 is required for proper male as well as female sexual development. Dev Biol 276(2):431-40. [PubMed: 15581876] [MGI Ref ID J:106304]
Jeays-Ward K; Hoyle C; Brennan J; Dandonneau M; Alldus G; Capel B; Swain A. 2003. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130(16):3663-70. [PubMed: 12835383] [MGI Ref ID J:84602]
Kim Y; Kobayashi A; Sekido R; DiNapoli L; Brennan J; Chaboissier MC; Poulat F; Behringer RR; Lovell-Badge R; Capel B. 2006. Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4(6):e187. [PubMed: 16700629] [MGI Ref ID J:110252]
Kispert A; Vainio S; Shen L; Rowitch DH; McMahon AP. 1996. Proteoglycans are required for maintenance of Wnt-11 expression in the ureter tips. Development 122(11):3627-37. [PubMed: 8951078] [MGI Ref ID J:36828]
Kobayashi A; Kwan KM; Carroll TJ; McMahon AP; Mendelsohn CL; Behringer RR. 2005. Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development. Development 132(12):2809-23. [PubMed: 15930111] [MGI Ref ID J:98831]
Kobayashi A; Shawlot W; Kania A; Behringer RR. 2004. Requirement of Lim1 for female reproductive tract development. Development 131(3):539-49. [PubMed: 14695376] [MGI Ref ID J:133086]
Louis I; Heinonen KM; Chagraoui J; Vainio S; Sauvageau G; Perreault C. 2008. The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity 29(1):57-67. [PubMed: 18617424] [MGI Ref ID J:137842]
Maatouk DM; DiNapoli L; Alvers A; Parker KL; Taketo MM; Capel B. 2008. Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet 17(19):2949-55. [PubMed: 18617533] [MGI Ref ID J:138861]
Mulroy T; McMahon JA; Burakoff SJ; McMahon AP; Sen J. 2002. Wnt-1 and Wnt-4 regulate thymic cellularity. Eur J Immunol 32(4):967-71. [PubMed: 11920562] [MGI Ref ID J:75999]
Ottolenghi C; Pelosi E; Tran J; Colombino M; Douglass E; Nedorezov T; Cao A; Forabosco A; Schlessinger D. 2007. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 16(23):2795-804. [PubMed: 17728319] [MGI Ref ID J:129972]
Park JS; Valerius MT; McMahon AP. 2007. Wnt/{beta}-catenin signaling regulates nephron induction during mouse kidney development. Development 134(13):2533-9. [PubMed: 17537789] [MGI Ref ID J:122521]
Perantoni AO; Timofeeva O; Naillat F; Richman C; Pajni-Underwood S; Wilson C; Vainio S; Dove LF; Lewandoski M. 2005. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 132(17):3859-71. [PubMed: 16049111] [MGI Ref ID J:101175]
Potok MA; Cha KB; Hunt A; Brinkmeier ML; Leitges M; Kispert A; Camper SA. 2008. WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. Dev Dyn 237(4):1006-20. [PubMed: 18351662] [MGI Ref ID J:132979]
Saitoh A; Hansen LA; Vogel JC; Udey MC. 1998. Characterization of Wnt gene expression in murine skin: possible involvement of epidermis-derived Wnt-4 in cutaneous epithelial-mesenchymal interactions. Exp Cell Res 243(1):150-60. [PubMed: 9716459] [MGI Ref ID J:49458]
Spater D; Hill TP; O'sullivan RJ; Gruber M; Conner DA; Hartmann C. 2006. Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis. Development 133(15):3039-49. [PubMed: 16818445] [MGI Ref ID J:119030]
Treier M; Gleiberman AS; O'Connell SM; Szeto DP; McMahon JA; McMahon AP; Rosenfeld MG. 1998. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12(11):1691-704. [PubMed: 9620855] [MGI Ref ID J:48144]
Vainio S; Heikkila M; Kispert A; Chin N; McMahon AP. 1999. Female development in mammals is regulated by Wnt-4 signalling. Nature 397(6718):405-9. [PubMed: 9989404] [MGI Ref ID J:52554]
Valerius MT; McMahon AP. 2008. Transcriptional profiling of Wnt4 mutant mouse kidneys identifies genes expressed during nephron formation. Gene Expr Patterns 8(5):297-306. [PubMed: 18346943] [MGI Ref ID J:133949]
Yao HH; Aardema J; Holthusen K. 2006. Sexually dimorphic regulation of inhibin Beta B in establishing gonadal vasculature in mice. Biol Reprod 74(5):978-83. [PubMed: 16452457] [MGI Ref ID J:107812]
Yao HH; Matzuk MM; Jorgez CJ; Menke DB; Page DC; Swain A; Capel B. 2004. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230(2):210-5. [PubMed: 15162500] [MGI Ref ID J:90277]
Currently there no information available for this strain. This may be due to the supply level of this strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000924 C57BL/6JEiJ | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.